Antibody Drug Conjugates Market Report – Research, Industry Analysis Reports and Market Demands

Antibody Drug Conjugates Market By Drug ( Adcetris, Kadcyla ), By Mechanism of Action ( CD30 Antibodies, HER2 Antibodies ), By Application ( Lymphoma, Breast cancer ), Industry Trends, Estimation & Forecast, 2017 - 2025

Request for Sample of this report

Buy now

Table of Content

CHAPTER 1. INTRODUCTION

1.1. RESEARCH METHODOLOGY
- 1.1.1. ERC desk research
- 1.1.2. ERC data synthesis
- 1.1.3. Data validation and market feedback
- 1.1.4. ERC data sources

CHAPTER 2. ANTIBODY DRUG CONJUGATES MARKET OVERVIEW

2.1. ANTIBODY DRUG CONJUGATES MARKET INTRODUCTION
2.2. GLOBAL ANTIBODY DRUG CONJUGATES MARKET REVENUE AND GROWTH RATE, 2017-2025
- 2.2.1. Global Antibody Drug Conjugates Market Revenue (Million USD) and Growth Rate (%), (2017-2025)

CHAPTER 3. GLOBAL ANTIBODY DRUG CONJUGATES MARKET BY DRUG, 2017-2025

3.1. ADCETRIS
3.2. KADCYLA
3.3. GLOBAL ANTIBODY DRUG CONJUGATES MARKET REVENUE BY DRUG, 2017-2025
- 3.3.1. Global Antibody Drug Conjugates Market Revenue (Million USD) and Share (%) By Drug, 2017-2025
- 3.3.2. Adcetris Market Revenue and Growth Rate, 2017-2025
- 3.3.3. Kadcyla Market Revenue and Growth Rate, 2017-2025

Note: Similar information coverage has been provided for by mechanism of action segment.

CHAPTER 4. GLOBAL ANTIBODY DRUG CONJUGATES MARKET BY APPLICATION, 2017-2025

4.1. LYMPHOMA
4.2. BREAST CANCER
4.3. OTHERS
4.4. GLOBAL ANTIBODY DRUG CONJUGATES MARKET REVENUE BY APPLICATION, 2017-2025
- 4.4.1. Global Antibody Drug Conjugates Market Revenue (Million USD) and Share (%) By Application, 2017-2025
- 4.4.2. Lymphoma Market Revenue and Growth Rate, 2017-2025
- 4.4.3. Breast cancer Market Revenue and Growth Rate, 2017-2025
- 4.4.4. Others Market Revenue and Growth Rate, 2017-2025

CHAPTER 5. GLOBAL ANTIBODY DRUG CONJUGATES MARKET BY REGION, 2017-2025

5.1. NORTH AMERICA
- 5.1.1. U.S.
- 5.1.2. Canada
- 5.1.3. Mexico
5.2. EUROPE
- 5.2.1. U.K.
- 5.2.2. France
- 5.2.3. Germany
- 5.2.4. Italy
- 5.2.5. Spain
- 5.2.6. Rest of Europe
5.3. ASIA PACIFIC
- 5.3.1. China
- 5.3.2. Japan
- 5.3.3. India
- 5.3.4. Korea
- 5.3.5. Rest of APAC
5.4. SOUTH AMERICA
- 5.4.1. Brazil
- 5.4.2. Rest of South America
5.5. REST OF THE WORLD
- 5.5.1. Middle East
- 5.5.2. Africa
5.6. GLOBAL ANTIBODY DRUG CONJUGATES MARKET REVENUE BY REGION, 2017-2025
- 5.6.1. Global Antibody Drug Conjugates Market Revenue (Million USD) and Share (%) By Region, 2017-2025
- 5.6.2. North America Market Revenue and Growth Rate, 2017-2025
- 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
- 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
- 5.6.5. South America Market Revenue and Growth Rate, 2017-2025
- 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

CHAPTER 6. MARKET DETERMINANTS

6.1. MARKET DRIVERS
6.2. MARKET RESTRAINTS
6.3. MARKET OPPORTUNITIES
6.4. MARKET DETERMINANTS RADAR CHART

CHAPTER 7. GLOBAL ANTIBODY DRUG CONJUGATES MARKET COMPETITION BY SERVICE PROVIDERS

7.1. GLOBAL ANTIBODY DRUG CONJUGATES REVENUE AND SHARE BY SERVICE PROVIDERS (2017-2025)
- 7.1.1. Global Antibody Drug Conjugates Revenue (Million USD) and Share (%) by Service Providers (2017-2025)
7.2. ANTIBODY DRUG CONJUGATES MARKET COMPETITIVE SITUATION AND TRENDS
- 7.2.1. Antibody Drug Conjugates Market Share (%) of Top 3 Service Providers
- 7.2.2. Antibody Drug Conjugates Market Share (%) of Top 5 Service Providers

CHAPTER 8. COMPANY PROFILES

CHAPTER 9. ANTIBODY DRUG CONJUGATES MARKET VALUE CHAIN ANALYSIS

9.1. ANTIBODY DRUG CONJUGATES INDUSTRIAL CHAIN ANALYSIS
9.2. CONSUMER ANALYSIS
- 9.2.1. Consumer 1
- 9.2.2. Consumer 2
- 9.2.3. Consumer 3

Description

“Antibody Drug Conjugates Market” 2018-2026 report is a professional study on the current state of the market that focuses on the major drivers, challenges, opportunities for the leading players. The research report also offers a granular analysis of various definitions, and classification of the industry, applications of the industry, regional breakdown, opportunities, challenges, and chain structure.

About Antibody Drug Conjugates Market

Antibody Drug Conjugates Market is expected to generate $3.2 Billion by the end of 2025. The global antibody drug conjugates market is growing at rapid pace due to increase in number of cancer patients worldwide. However, the market is in infancy stage as only two drugs are being marketed and several ADCs are under last stages of its clinical development. Factors such as an increase in consumption in tobacco and alcohol, sedentary lifestyle, and increasing the number of cancer patients across the globe are driving the growth of the market. Moreover, rising awareness among consumer regarding ADC therapy, increasing demand for cost-effective cancer treatment and extensive research and development activities carried by market players boosts market growth.

Market Summary:

The Antibody Drug Conjugates market is a comprehensive report which offers a meticulous overview of the market share, size, trends, demand, product analysis, application analysis, regional outlook, competitive strategies, forecasts, and strategies impacting the Antibody Drug Conjugates Industry. The report includes a detailed analysis of the market competitive landscape, with the help of detailed business profiles, SWOT analysis, project feasibility analysis, and several other details about the key companies operating in the market.

The study on the worldwide Antibody Drug Conjugates market strives to offer substantial and profound insights into the current market scenario and the developing growth dynamics. Moreover, the report also provides the market players along with the new contenders a complete view of the market landscape. The inclusive research will enable the well-established as well as the entry-level players to establish their business strategies and accomplish their short-term and long-term goals.

Scope and Segmentation of the Report

The segment analysis is one of the significant sections of this report. Our expert analyst has categorized the market into product type, application/end-user, and geography. All the segments are analyzed based on their market share, growth rate, and growth potential. In the geographical classification, the report highlights the regional markets having high growth potential. This thorough evaluation of the segments would help the players to focus on revenue-generating areas of the Antibody Drug Conjugates market.

Based on Type

By Drug
Adcetris
Kadcyla

Based on Application

Lymphoma
Breast cancer
Others

Regional Analysis

Our analysts are experts in covering all types of geographical markets from developing to mature ones. You can expect a comprehensive research analysis of key regional and country-level markets such as Europe, North America, South America, Asia-Pacific, and the Middle East & Africa. With accurate statistical patterns and regional classification, our domain experts provide you one of the most detailed and easily understandable regional analyses of the Antibody Drug Conjugates market.

Competitive Landscape:

The research report also studied the key players operating in the Antibody Drug Conjugates market. It has evaluated and explained the research & development stages of these companies, their financial performances, and their expansion plans for the coming years. Moreover, the research report also includes the list of planned initiatives that clearly explain the accomplishments of the companies in the recent past.

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products, etc.):

Seattle Genetics Inc.
Roche Holding AG
ImmunoGen
Inc.
Genentech Inc.
Agensys
Inc.
Bayer Healthcare Pharmaceuticals
Vaccinex Inc.
Concortis Biotherapeutics
Celldex Therapeutics Inc.
Daiichi Sankyo

Research Methodology

The research methodology of the market is based on both primary as well as secondary research data sources. It compels different factors affecting the Antibody Drug Conjugates industry such as historical data and market trends, different policies of the government, market environment, market risk factors, market restraints, technological advancements, forthcoming innovations, and obstacles in the industry.

The content of the study subjects includes a total of 8 chapters:

Chapter 1, describe the Antibody Drug Conjugates market report’s – executive summary, market definition, and market scope. Moreover, the report helps in picking up the crucial information about the said market.

Chapter 2, defines the Research Methodology including primary research, assumptions & exclusions, and secondary data sources. The report follows the simultaneous top-down and bottom approach to provide you the accurate market sizing.

Chapter 3, explains the report segmentation & scope, key market trends (drivers, restraints, and opportunities), along with Porter’s five forces analysis and market share analysis

Chapter 4: It helps in understanding the key product segments and their future of the Antibody Drug Conjugates Market. It provides strategic recommendations in key business segments based on the market estimations.

Chapters 5, and 6 to segment the sales by type and application/end-user, with sales market share and growth rate by type, application/end-user, from 2018 to 2016. Our team of Analysts and experts dedicatedly put their effort to provide you the best possible and accurate segmentation data and analysis.

Chapter 7, describes the regional segmentation based on the country level for the forecast period 2018 – 2026. The research report not only provide the market data of the five geographies but also provide the qualitative as well we qualitative information on country level bifurcation.

Chapter 8, to profile the top manufacturers of Antibody Drug Conjugates, with price, sales, revenue and market share of Antibody Drug Conjugates in 2016, 2017, and 2018. Players are expected to sign acquisition and collaboration deals to expand their products and services portfolio. Such strategic agreements could help them to improve their client base in other countries and gain a competitive advantage

Buy now